Literature DB >> 7509002

Antigenicity of the N8 influenza A virus neuraminidase: existence of an epitope at the subunit interface of the neuraminidase.

T Saito1, G Taylor, W G Laver, Y Kawaoka, R G Webster.   

Abstract

To locate antigenic epitopes on the N8 neuraminidase (NA), we generated a panel of 97 monoclonal antibodies (MAbs), 66 of which inhibited NA activity (NI antibodies). Three groups of NI MAbs were identified from their different reactivities with escape mutants. Group 1 antibodies recognized the peptide loop containing residues 344 to 346, which appears to be an immunodominant region on the rim of the enzyme center of the N8 NA. Group 2 antibodies recognized a novel epitope containing residues 150, 199, 367, 399, and 400 (N2 numbering). From the location of these residues on the three-dimensional structure of the N8 NA, the epitope appears to be located at the interface of two adjacent monomers in the tetrameric NA, one contributing residues 150 and 199 and the other contributing residues 367 and 399 to 400. The available evidence indicates that the MAbs of this group react with the NA only after it is fully assembled. The third group of antibodies recognized the peptide loops containing residues 367 and 399 to 400. All of the amino acid substitutions in N8 escape mutants which affect the NI activity of antibodies were located in the peptide loops known to form epitopes in the N2 and N9 subtypes, indicating that antigenic regions in the NA head inducing NI antibodies appear to be similar among different subtypes of influenza A viruses. The MAbs used in this study will be valuable in studying the role of each N8 NA epitope in host immune defense systems and in the kinetics analysis of the biosynthesis of the enzyme.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7509002      PMCID: PMC236640     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  28 in total

1.  Mechanism of antigenic variation in an individual epitope on influenza virus N9 neuraminidase.

Authors:  G M Air; W G Laver; R G Webster
Journal:  J Virol       Date:  1990-12       Impact factor: 5.103

2.  Refined atomic structures of N9 subtype influenza virus neuraminidase and escape mutants.

Authors:  W R Tulip; J N Varghese; A T Baker; A van Donkelaar; W G Laver; R G Webster; P M Colman
Journal:  J Mol Biol       Date:  1991-09-20       Impact factor: 5.469

Review 3.  The neuraminidase of influenza virus.

Authors:  G M Air; W G Laver
Journal:  Proteins       Date:  1989

4.  Synthesis and processing of the influenza virus neuraminidase, a type II transmembrane glycoprotein.

Authors:  B G Hogue; D P Nayak
Journal:  Virology       Date:  1992-06       Impact factor: 3.616

5.  Antigenic structure and variation in an influenza virus N9 neuraminidase.

Authors:  R G Webster; G M Air; D W Metzger; P M Colman; J N Varghese; A T Baker; W G Laver
Journal:  J Virol       Date:  1987-09       Impact factor: 5.103

6.  Deglycosylation of asparagine-linked glycans by peptide:N-glycosidase F.

Authors:  A L Tarentino; C M Gómez; T H Plummer
Journal:  Biochemistry       Date:  1985-08-13       Impact factor: 3.162

7.  Three-dimensional structure of the neuraminidase of influenza virus A/Tokyo/3/67 at 2.2 A resolution.

Authors:  J N Varghese; P M Colman
Journal:  J Mol Biol       Date:  1991-09-20       Impact factor: 5.469

8.  Refined crystal structure of the influenza virus N9 neuraminidase-NC41 Fab complex.

Authors:  W R Tulip; J N Varghese; W G Laver; R G Webster; P M Colman
Journal:  J Mol Biol       Date:  1992-09-05       Impact factor: 5.469

9.  Folding, interaction with GRP78-BiP, assembly, and transport of the human immunodeficiency virus type 1 envelope protein.

Authors:  P L Earl; B Moss; R W Doms
Journal:  J Virol       Date:  1991-04       Impact factor: 5.103

10.  The 2.2 A resolution crystal structure of influenza B neuraminidase and its complex with sialic acid.

Authors:  W P Burmeister; R W Ruigrok; S Cusack
Journal:  EMBO J       Date:  1992-01       Impact factor: 11.598

View more
  15 in total

1.  Impact of quaternary organization on the antigenic structure of the tick-borne encephalitis virus envelope glycoprotein E.

Authors:  Stefan Kiermayr; Karin Stiasny; Franz X Heinz
Journal:  J Virol       Date:  2009-06-24       Impact factor: 5.103

Review 2.  Biosensor-based epitope mapping of antibodies targeting the hemagglutinin and neuraminidase of influenza A virus.

Authors:  Zhu Guo; Jason R Wilson; Ian A York; James Stevens
Journal:  J Immunol Methods       Date:  2018-07-24       Impact factor: 2.303

3.  The arrival of highly pathogenic avian influenza viruses H5N8 in Iran through two windows, 2016.

Authors:  Minoo Motahhar; Hadi Keyvanfar; Abdolhamid Shoushtari; Mohammad Hossein Fallah Mehrabadi; Gholamreza Nikbakht Brujeni
Journal:  Virus Genes       Date:  2022-09-13       Impact factor: 2.198

4.  Steps in maturation of influenza A virus neuraminidase.

Authors:  T Saito; G Taylor; R G Webster
Journal:  J Virol       Date:  1995-08       Impact factor: 5.103

5.  Genetic Analysis of the Neuraminidase (NA) Gene of Equine Influenza Virus (H3N8) from Epizootic of 2008-2009 in India.

Authors:  B C Bera; N Virmani; K Shanmugasundaram; R K Vaid; B K Singh; B R Gulati; T Anand; S Barua; P Malik; R K Singh
Journal:  Indian J Virol       Date:  2013-05-24

6.  An influenza A virus (H7N9) anti-neuraminidase monoclonal antibody with prophylactic and therapeutic activity in vivo.

Authors:  Jason R Wilson; Zhu Guo; Adrian Reber; Ram P Kamal; Nedzad Music; Shane Gansebom; Yaohui Bai; Min Levine; Paul Carney; Wen-Pin Tzeng; James Stevens; Ian A York
Journal:  Antiviral Res       Date:  2016-10-03       Impact factor: 5.970

7.  Epitope determinants of a chimpanzee Fab antibody that efficiently cross-neutralizes dengue type 1 and type 2 viruses map to inside and in close proximity to fusion loop of the dengue type 2 virus envelope glycoprotein.

Authors:  Ana P Goncalvez; Robert H Purcell; Ching-Juh Lai
Journal:  J Virol       Date:  2004-12       Impact factor: 5.103

8.  Thiopurines activate an antiviral unfolded protein response that blocks influenza A virus glycoprotein accumulation.

Authors:  Patrick D Slaine; Mariel Kleer; Brett A Duguay; Eric S Pringle; Eileigh Kadijk; Shan Ying; Aruna Balgi; Michel Roberge; Craig McCormick; Denys A Khaperskyy
Journal:  J Virol       Date:  2021-03-24       Impact factor: 5.103

Review 9.  Influenza neuraminidase.

Authors:  Gillian M Air
Journal:  Influenza Other Respir Viruses       Date:  2011-11-16       Impact factor: 4.380

10.  Influenza H7N9 Virus Neuraminidase-Specific Human Monoclonal Antibodies Inhibit Viral Egress and Protect from Lethal Influenza Infection in Mice.

Authors:  Iuliia M Gilchuk; Sandhya Bangaru; Pavlo Gilchuk; Ryan P Irving; Nurgun Kose; Robin G Bombardi; Natalie J Thornburg; C Buddy Creech; Kathryn M Edwards; Sheng Li; Hannah L Turner; Wenli Yu; Xueyong Zhu; Ian A Wilson; Andrew B Ward; James E Crowe
Journal:  Cell Host Microbe       Date:  2019-11-19       Impact factor: 31.316

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.